within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M05B_DrugsAffectingBoneStructureAndMineralization.M05BC02_EptoterminAlfa;

model EptoterminAlfa
  extends Pharmacolibrary.Drugs.ATC.M.M05BC02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M05BC02</td></tr><td>route:</td><td></td></tr><tr><td>n-compartments</td><td>0</td></tr></table><p>Eptotermin alfa, also known as recombinant human bone morphogenetic protein-7 (rhBMP-7), is a bone morphogenetic protein used to stimulate bone growth in non-union fractures and certain spinal fusions. It was previously approved for orthopedic use but is no longer widely marketed or approved today in most countries.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic model parameters have been published in the scientific literature for eptotermin alfa (rhBMP-7) in humans.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end EptoterminAlfa;
